Cost effectiveness of angiotensin receptor blocker monotherapy in patients with hypertension in the Netherlands: a comparative analysis using clinical trial and drug utilization data.


BACKGROUND AND OBJECTIVE Health gains and related cost savings achieved by optimizing treatment in hypertensive patients is highly important. The aim of this study was to evaluate the costs and cost effectiveness of treatment with angiotensin II receptor antagonists (angiotensin II receptor blockers [ARBs]) in patients with essential hypertension and to… (More)
DOI: 10.2165/11319570-000000000-00000


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics